Anti-Mouse CD7 [Clone JD23] — CF®647

Anti-Mouse CD7 [Clone JD23] — CF®647

Product No.: LT7096CF

[product_table name="All Top" skus="C2822"]

- -
- -
Product No.LT7096CF
Clone
JD23
Target
CD7
Product Type
Recombinant Monoclonal Antibody
Isotype
Mouse IgG1 κ
Applications
FA
,
FC

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Mouse
Product Concentration
0.2 mg/ml
Formulation
This CF®647 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
State of Matter
Liquid
Storage and Handling
This CF®647 conjugate is stable when stored at 2-8°C, protected from light. Do not freeze.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2-8°C
Excitation Laser
650 nm
Additional Reported Applications For Relevant Conjugates ?
Functional Assay (FA): JD23 is a mouse CD7‑specific antibody that recognize cell‑surface mCD7; however, only CAR‑T cells engineered with the JD23‑derived scFv mediate potent and specific killing of mCD7‑positive tumor cells in vitro.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Emission Max
665 nm

Description

Description

Specificity
This antibody specifically recognizes mouse CD7 (mCD7) and shows no detectable cross‑reactivity with unrelated mouse surface markers under the tested conditions. Binding has been confirmed on mCD7‑expressing cells and is absent on mCD7‑negative control cells and isotype controls, supporting its suitability for specific detection of mouse CD7 in immunological and CAR‑T–related applications.
Background
CD7 (Leu-9): A Key Marker in T-Cell Biology and CAR-T Research
CD7, also known as Leu-9, is an approximately 40 kD glycosylated and palmitoylated transmembrane protein belonging to the immunoglobulin superfamily. As a critical surface antigen, CD7 plays a significant role in immune regulation and oncology research.

Molecular Characteristics and Homology
The extracellular domain of mature mouse CD7 shares specific amino acid sequence similarities with other species, making it a vital focus for cross-species comparative studies:

81% similarity with rat CD7.

43% similarity with human CD7.

CD7 Expression and Localization
In mice, CD7 mRNA is predominantly detected in lymphoid and mucosal tissues, reflecting its role in the immune system. Key expression sites include:

-Thymus and Spleen
-Bone Marrow
- Small Intestine

This expression pattern is consistent with its presence on T cells and NK cell subsets, where it assists in various stages of immune signaling.

Research Applications: Leukemia and CAR-T Therapy
While the physiological ligand and exact function of mouse CD7 are still being defined, it remains a high-value biomarker and therapeutic target. Its primary applications include:

- T-cell activation and signaling research. - Leukemia and lymphoma diagnostics and monitoring.

Next-generation CAR-T cell development, specifically for targeting T-cell malignancies.
Antigen Distribution
Mouse CD7 mRNA exists in thymus, spleen, bone marrow, and small intestine
Ligand/Receptor
Hematopoietic stem and progenitors, Leukemia, NK cells, T cells, Thymocytes

References & Citations

1. Kim MY, Cooper ML, Jacobs MT, Ritchey JK, Hollaway J, Fehniger TA, DiPersio JF. CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy. JCI Insight. 2021 Aug 23;6(16):e149819. doi: 10.1172/jci.insight.149819. PMID: 34423790; PMCID: PMC8410010.
FA
Flow Cytometry

Certificate of Analysis

Formats Available

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.